CNIO - Spanish National Cancer Research Centre
Francisca Mulero is a seasoned professional in the field of molecular imaging and nuclear medicine with extensive experience since 2007 as the Head of the Molecular Imaging Department at the Spanish National Cancer Research Centre (CNIO). Currently serving as an imaging expert at the IMAGE ANALYSIS GROUP since January 2020, Francisca Mulero specializes in oncology, particularly in preclinical and clinical PET imaging. As Chief of the Advisory Board for the MIT M+Vision Consortium, Francisca Mulero plays a pivotal role in the IDEA3 Fellowship Program and co-chairs the selection committee. Previous experience includes a position as a Nuclear Medicine Specialist at Hospital Virgen de la Arrixaca from 1994 to January 2007, focusing on PET imaging and metabolic therapy. Educational qualifications include degrees in Medicine and Surgery, a Doctor of Philosophy in Medicine, and management training tailored for scientists and researchers.
This person is not in any teams
CNIO - Spanish National Cancer Research Centre
The Spanish National Cancer Research Centre is a public institution of excellence committed to research, diagnosis and treatment for cancer. The CNIO currently houses 22 Research Groups, organised in 7 Scientific Programmes, plus 5 Clinical Research Unit(s) that work closely with several hospitals. These scientific groups are supported by 19 Core Units that provide state-of-the-art facilities and technical expertise. The CNIO also has an Experimental Therapeutics Programme leader in academic drug discovery. Since 2011, CNIO is recognised a one of the ‘Severo Ochoa’ Centres of Excellence by the Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación -------------------------------- El Centro Nacional de Investigaciones Oncológicas (CNIO) es una institución pública española dedicada a la investigación, diagnóstico y tratamiento del cáncer. El CNIO cubre todo el recorrido de la I+D+i, desde la investigación básica hasta la clínica. Actualmente el CNIO tiene 22 Grupos de Investigación, organizados en 7 Programas Científicos, más 5 Unidades de Investigación Clínica que trabajan estrechamente con varios hospitales. En el CNIO hay 19 Unidades de Apoyo a la Investigación dotadas de las más modernas instalaciones y conocimientos técnicos. El CNIO también tiene un Programa de Terapias Experimentales de referencia en el descubrimiento de nuevos fármacos. Desde el 2011, el CNIO es uno de los Centros de Excelencia Severo Ochoa acreditados por la Agencia Estatal de Investigación, Ministerio de Ciencia e Innovación.